NO170913C - Fremgangsmåte for fremstilling av en injiserbar opplösning inneholdende etantitumorantracyklin-glykosid - Google Patents

Fremgangsmåte for fremstilling av en injiserbar opplösning inneholdende etantitumorantracyklin-glykosid

Info

Publication number
NO170913C
NO170913C NO19862587A NO862587A NO170913C NO 170913 C NO170913 C NO 170913C NO 19862587 A NO19862587 A NO 19862587A NO 862587 A NO862587 A NO 862587A NO 170913 C NO170913 C NO 170913C
Authority
NO
Norway
Prior art keywords
ethanitite
preparation
solution containing
injectable solution
anthracycline glycoside
Prior art date
Application number
NO19862587A
Other languages
English (en)
Norwegian (no)
Other versions
NO862587D0 (no
NO170913B (no
NO862587L (no
Inventor
Gaetano Gatti
Diego Oldani
Giuseppe Bottoni
Carlo Confalonieri
Luciano Gambini
Roberto De Ponti
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10583216&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO170913(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Publication of NO862587D0 publication Critical patent/NO862587D0/no
Publication of NO862587L publication Critical patent/NO862587L/no
Publication of NO170913B publication Critical patent/NO170913B/no
Publication of NO170913C publication Critical patent/NO170913C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • C07H15/252Naphthacene radicals, e.g. daunomycins, adriamycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
NO19862587A 1985-08-02 1986-06-26 Fremgangsmåte for fremstilling av en injiserbar opplösning inneholdende etantitumorantracyklin-glykosid NO170913C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858519452A GB8519452D0 (en) 1985-08-02 1985-08-02 Injectable solutions

Publications (4)

Publication Number Publication Date
NO862587D0 NO862587D0 (no) 1986-06-26
NO862587L NO862587L (no) 1987-02-03
NO170913B NO170913B (no) 1992-09-21
NO170913C true NO170913C (no) 2003-10-10

Family

ID=10583216

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19862587A NO170913C (no) 1985-08-02 1986-06-26 Fremgangsmåte for fremstilling av en injiserbar opplösning inneholdende etantitumorantracyklin-glykosid

Country Status (34)

Country Link
US (1) US4946831A (it)
JP (1) JPH0655667B2 (it)
KR (1) KR920001773B1 (it)
CN (1) CN1064531C (it)
AT (1) AT397463B (it)
BE (1) BE905202A (it)
BG (1) BG60425B2 (it)
CA (1) CA1291037C (it)
CH (2) CH668911C1 (it)
CS (1) CS277561B6 (it)
CY (1) CY1592A (it)
DE (1) DE3621844C2 (it)
DK (1) DK167557B1 (it)
ES (1) ES8801580A1 (it)
FI (1) FI86800C (it)
FR (1) FR2585569B1 (it)
GB (2) GB8519452D0 (it)
GR (1) GR861556B (it)
HK (1) HK93990A (it)
HU (1) HU196123B (it)
IE (1) IE59297B1 (it)
IL (1) IL79129A (it)
IT (1) IT1204906B (it)
NL (2) NL191507C (it)
NO (1) NO170913C (it)
NZ (1) NZ216604A (it)
PH (1) PH22332A (it)
PT (1) PT82865B (it)
RU (2) RU1837883C (it)
SE (1) SE466383C (it)
SG (1) SG80690G (it)
UA (1) UA29383C2 (it)
YU (1) YU44788B (it)
ZA (1) ZA864792B (it)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124317A (en) 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.P.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5124318A (en) * 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.R.L. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5977082A (en) 1985-08-02 1999-11-02 Pharmacia & Upjohn Company Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
ES2198424T3 (es) * 1986-12-05 2004-02-01 Pharmacia Italia S.P.A. Soluciones inyectables listas para el empleo que contienen doxorrubicina.
FI883337A (fi) * 1987-07-16 1989-01-17 Bristol Myers Co Icke-vattenloesningar av doxorubicinhydroklorin.
FI883338A (fi) * 1987-07-16 1989-01-17 Bristol Myers Co Vattenloesningar av doxorubicinhydroklorid.
DE3801178A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierte trockenzubereitung zytostatisch wirksamer anthracyclin-antibiotika und verfahren zu ihrer herstellung
JPH02200636A (ja) * 1988-12-05 1990-08-08 Bristol Myers Squibb Co ドキソルビシン非水溶液
FI895733A0 (fi) * 1988-12-05 1989-11-30 Bristol Myers Squibb Co Vattenloesningar av doxorubicin.
GB9200247D0 (en) * 1992-01-07 1992-02-26 Erba Carlo Spa Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation
DE19544532C2 (de) * 1995-11-29 1997-12-11 Pharma Dynamics Gmbh Verfahren zum Herstellen eines Doxorubicin-Lyophilisats
SI0848009T1 (en) * 1996-12-16 2000-12-31 Pharmachemie B.V. A process for preparing epirubicin or acid addition salts thereof from daunorubicin
ATE357214T1 (de) 1996-12-30 2007-04-15 Battelle Memorial Institute Verwendung eines unverkapselten anti-krebs- wirkstoffs zur herstellung einer zubereitung zur behandlung von neoplasmen durch inhalation
US20090253220A1 (en) * 2003-10-28 2009-10-08 Sukanta Banerjee Absorbing Biomolecules into Gel-Shell Beads
BRPI0605832A2 (pt) * 2005-05-11 2009-05-26 Sicor Inc glicosìdeos de antraciclina liofilizados estáveis
US20140378404A1 (en) * 2011-10-25 2014-12-25 Nektar Therapeutics Treatment of Patients Suffering from Cancer
CN102614118B (zh) * 2012-03-15 2014-04-30 北京协和药厂 注射用盐酸表柔比星制剂的制备方法及制剂

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU33730B (en) * 1967-04-18 1978-02-28 Farmaceutici Italia Process for preparing a novel antibiotic substance and salts thereof
GB1457632A (en) * 1974-03-22 1976-12-08 Farmaceutici Italia Adriamycins
GB1500421A (en) * 1975-01-22 1978-02-08 Farmaceutici Italia Optically active anthracyclinones
US4039663A (en) * 1975-03-19 1977-08-02 Societa' Farmaceutici Italia S.P.A. Daunomycins, process for their uses and intermediates
FR2314726A1 (fr) * 1975-06-16 1977-01-14 Rhone Poulenc Ind Nouveaux derives du naphtagene, leur preparation et les compositions qui les contiennent
GB1511559A (en) * 1975-09-26 1978-05-24 Farmaceutici Italia Anthracycline glycosides
FR2397425A1 (fr) * 1977-07-11 1979-02-09 Rhone Poulenc Ind Nouveaux derives de la daunorubicine, leur preparation et les compositions qui les contiennent
DE2738656A1 (de) * 1977-08-26 1979-03-08 Microbial Chem Res Found Anthracyclinglycoside, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4177264A (en) * 1977-10-17 1979-12-04 Sri International N-benzyl anthracyclines
GB2007645B (en) * 1977-10-17 1982-05-12 Stanford Res Inst Int Benzyl anthracyclines and pharmaceutical compositions containing them
FR2430425A1 (fr) * 1978-07-07 1980-02-01 Rhone Poulenc Ind Nouveaux derives de la daunorubicine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2433027A1 (fr) * 1978-08-08 1980-03-07 Rhone Poulenc Ind Nouveau procede de preparation de derives de la doxorubicine
US4325947A (en) * 1981-05-12 1982-04-20 Farmitalia Carlo Erba S.P.A. 4-Demethoxy-4'-deoxydoxorubicin
US4438105A (en) * 1982-04-19 1984-03-20 Farmaitalia Carlo Erba S.P.A 4'-Iododerivatives of anthracycline glycosides
US4464529A (en) * 1982-07-20 1984-08-07 Sri International Analogues of morpholinyl daunorubicin and morpholinyl doxorubicin
JPS6092212A (ja) * 1983-10-26 1985-05-23 Kyowa Hakko Kogyo Co Ltd ドキソルビシン塩の製剤
ES2198424T3 (es) * 1986-12-05 2004-02-01 Pharmacia Italia S.P.A. Soluciones inyectables listas para el empleo que contienen doxorrubicina.

Also Published As

Publication number Publication date
CN1064531C (zh) 2001-04-18
GB2178311A (en) 1987-02-11
BE905202A (fr) 1987-02-02
DE3621844C2 (de) 1994-02-17
DK306286A (da) 1987-02-03
CH668911A5 (de) 1989-02-15
CA1291037C (en) 1991-10-22
RU1837883C (ru) 1993-08-30
CS470886A3 (en) 1992-11-18
SE8602743L (sv) 1987-02-03
UA29383C2 (uk) 2000-11-15
FI862629A (fi) 1987-02-03
ES8801580A1 (es) 1988-02-16
NL300011I1 (nl) 2000-10-02
RU2110263C1 (ru) 1998-05-10
NO862587D0 (no) 1986-06-26
ATA176886A (de) 1993-09-15
US4946831A (en) 1990-08-07
IT8620917A0 (it) 1986-06-26
YU103586A (en) 1988-04-30
HK93990A (en) 1990-11-23
PT82865A (en) 1986-07-01
SE466383C (sv) 1996-02-19
FI86800C (fi) 1999-10-28
NL191507B (nl) 1995-04-18
IL79129A0 (en) 1986-09-30
CS277561B6 (en) 1993-03-17
CN86104283A (zh) 1987-01-28
GB8614800D0 (en) 1986-07-23
FR2585569B1 (fr) 1990-01-19
AU598197B2 (en) 1990-06-21
SE466383B (sv) 1992-02-10
CH668911C1 (de) 2000-05-31
CY1592A (en) 1992-04-03
CH690490C2 (de) 2000-09-29
PH22332A (en) 1988-07-29
DE3621844A1 (de) 1987-03-05
DK306286D0 (da) 1986-06-27
HU196123B (en) 1988-10-28
ES556291A0 (es) 1988-02-16
KR920001773B1 (ko) 1992-03-02
NL8601698A (nl) 1987-03-02
PT82865B (pt) 1989-01-17
FI862629A0 (fi) 1986-06-19
NO170913B (no) 1992-09-21
JPH0655667B2 (ja) 1994-07-27
SE8602743D0 (sv) 1986-06-19
AT397463B (de) 1994-04-25
AU5885886A (en) 1987-02-12
GR861556B (en) 1986-10-17
KR870001828A (ko) 1987-03-28
YU44788B (en) 1991-02-28
BG60425B2 (bg) 1995-03-31
DK167557B1 (da) 1993-11-22
IE861598L (en) 1987-02-02
NO862587L (no) 1987-02-03
IT1204906B (it) 1989-03-10
JPS6248629A (ja) 1987-03-03
ZA864792B (en) 1988-02-24
IL79129A (en) 1992-03-29
SG80690G (en) 1990-11-23
NL191507C (nl) 2000-02-16
FR2585569A1 (fr) 1987-02-06
FI86800B (fi) 1992-07-15
HUT42326A (en) 1987-07-28
NZ216604A (en) 1989-10-27
GB8519452D0 (en) 1985-09-11
IE59297B1 (en) 1994-02-09
GB2178311B (en) 1989-10-11

Similar Documents

Publication Publication Date Title
NO170913C (no) Fremgangsmåte for fremstilling av en injiserbar opplösning inneholdende etantitumorantracyklin-glykosid
YU164485A (en) Process for production of solution for injections containing anticylinic glycoside
RO89963A (ro) Procedeu pentru prepararea unor difluoronucleozide
PT83643B (pt) Processo de preparacao de derivados de quinoleina
PT81730A (en) Process for the preparation of acylated cyclic dihetonic compounds
IT1110507B (it) Procedimento per produrre cristalli misti di (u,pu) 02
GR861841B (en) Process for the preparation of poly-4-aminopyrrole-2-carboxamido derivatives
FR2585707B1 (fr) Procede de preparation de monosialoganglioside
GR861380B (en) Process for the preparation of gamma-globulines administrating intravenous
EP0201067A3 (en) Process for the preparation of isosorbide-5-mononitrate
EP0226543A3 (en) Process for the preparation of glycidyl compounds
FI885045A (fi) Menetelmä polynukleotidien valmistamiseksi
NO174085C (no) Fremgangsmåte for fremstilling av sukralfatpreparater
FI863282A0 (fi) Uusi menetelmä valmistaa metyleenidioksifenantreeniyhdisteitä
GB8621148D0 (en) Deinterleaving of radiated signals
PT82873A (en) Process for the preparation of novel secocanthine derivatives
ZA865376B (en) Process for the preparation of 2-cyanoamino-pyrimidine derivatives
IT8548226A0 (it) Composizione per inibire lo sviluppo di tumori e procedimento per lasua preparazione
DE3468219D1 (en) Stereoselective process for the preparation of anthracycline derivatives
GR880100755A (el) Μέ?οδος παρασκευής νέων παραγώγων 4-δεμε?οξυαν?ρακυκλίνης.
PT87593A (pt) Process for the preparation of nucleosides and of pharmaceutical compounds containing them
HUT41816A (en) Process for producing compounds of spergualin-like structure
PT88465A (pt) Process for the preparation of macrolide compounds
PT88467A (pt) Process for the preparation of macrolide compounds
GR861026B (en) Process for the preparation of eburnamenine derivatives

Legal Events

Date Code Title Description
MK1K Patent expired